Circulating Endothelial Progenitor Cells Decreased in Patients with Sclerodermatous Chronic Graft-versus-Host Disease

Biology of Blood and Marrow Transplantation

Volumn 14, Issue 4, 2008, Pages 426-437

  Shimura, Kazuho ^a   Ashihara, Eishi ^b   Shimazaki, Chihiro ^a   Matsunaga, Shinsaku ^a   Taniguchi, Kyoko ^a   Uchiyama, Hitoji ^a   Matsumoto, Yosuke ^a   Kimura, Shinya ^b   Matsubara, Hiroaki ^a   Taniwaki, Masafumi ^a   Maekawa, Taira ^b  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Allogeneic stem cell transplantation; CD34; Endothelial progenitor cells; Sclerodermatous chronic GVHD; VEGR 2

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; BUSULFAN; CD133 ANTIGEN; CD34 ANTIGEN; CLADRIBINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETOPOSIDE; FLUDARABINE; MELPHALAN; PREDNISOLONE; TACROLIMUS; THYMOCYTE ANTIBODY; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ANGIOGENESIS; APLASTIC ANEMIA; ARTICLE; BLOOD FLOW; BLOOD SAMPLING; CELL SELECTION; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; COLONY FORMATION; COLONY FORMING UNIT; CONCENTRATION (PARAMETERS); ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MALIGNANT HISTIOCYTOSIS; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; QUANTITATIVE ANALYSIS; SCLERODERMA; SKIN DEFECT; STEM CELL; WHOLE BODY RADIATION;

ACUTE DISEASE; ADULT; AGED; ANTIGENS, CD; ANTIGENS, CD34; CHRONIC DISEASE; COLONY-FORMING UNITS ASSAY; ENDOTHELIUM, VASCULAR; FEMALE; GRAFT VS HOST DISEASE; HUMANS; MALE; MIDDLE AGED; REFERENCE VALUES; SCLERODERMA, LIMITED; STEM CELLS; TRANSPLANTATION, HOMOLOGOUS;

EID: 40649085614     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2008.02.001     Document Type: Article

References (30)

1. Farag S.S. Chronic graft-versus-host disease: where do we go from here?. Bone Marrow Transplant 33 (2004) 569-577
2. Biedermann B.C., Sahner S., Gregor M., et al. Endothelial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft versus host disease. Lancet 359 (2002) 2078-2083
3. Zhang C., Todorov I., Zhang Z., et al. Donor CD4+ T and B cells in transplants induce chronic graft-versus-host disease with autoimmune manifestations. Blood 107 (2006) 2993-3001
4. LeRoy E.C. Systemic sclerosis. A vascular perspective. Rheum Dis Clin North Am 22 (1996) 675-694
5. Kuwana M., Okazaki Y., Yasuoka H., Kawakami Y., and Ikeda Y. Defective vasculogenesis in systemic sclerosis. Lancet 364 (2004) 603-610
6. Glucksberg H., Storb R., Fefer A., et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 18 (1974) 295-304
7. Shulman H.M., Sullivan K.M., Weiden P.L., et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 69 (1980) 204-217
8. Lee S.J., Vogelsang G., and Flowers M.E. Chronic graft-versus-host disease. Biol Blood Marrow Transplant 9 (2003) 215-233
9. Filipovich A.H., Weisdorf D., Pavletic S., et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 11 (2005) 945-956
10. Sutherland D.R., Anderson L., Keeney M., Nayar R., and Chin-Yee I. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother 5 (1996) 213-226
11. Rafii S., and Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 9 (2003) 702-712
12. Massa M., Rosti V., Ferrario M., et al. Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood 105 (2005) 199-206
13. Takahashi T., Kalka C., Masuda H., et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 5 (1999) 434-438
14. Poloni A., Leoni P., Buscemi L., et al. Engraftment capacity of mesenchymal cells following hematopoietic stem cell transplantation in patients receiving reduced-intensity conditioning regimen. Leukemia 20 (2006) 329-335
15. Valentini G., D'Angelo S., Della Rossa A., Bencivelli W., and Bombardieri S. European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. IV. Assessment of skin thickening by modified Rodnan skin score. Ann Rheum Dis 62 (2003) 904-905
16. Skert C., Patriarca F., Sperotto A., et al. Sclerodermatous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: incidence, predictors and outcome. Haematologica 91 (2006) 258-261
17. Sanchez-Guijo F.M., Sanchez-Abarca L.I., Villaron E., et al. Posttransplant hematopoiesis in patients undergoing sibling allogeneic stem cell transplantation reflects that of their respective donors although with a lower functional capability. Exp Hematol 33 (2005) 935-943
18. Woywodt A., Scheer J., Hambach L., et al. Circulating endothelial cells as a marker of endothelial damage in allogeneic hematopoietic stem cell transplantation. Blood 103 (2004) 3603-3605
19. Asahara T., Murohara T., Sullivan A., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275 (1997) 964-967
20. Vasa M., Fichtlscherer S., Aicher A., et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89 (2001) E1-E7
21. Hill J.M., Zalos G., Halcox J.P., et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348 (2003) 593-600
22. Numaguchi Y., Sone T., Okumura K., et al. The impact of the capability of circulating progenitor cell to differentiate on myocardial salvage in patients with primary acute myocardial infarction. Circulation 114 1 Suppl (2006) I114-I119
23. Masuda H., and Asahara T. Post-natal endothelial progenitor cells for neovascularization in tissue regeneration. Cardiovasc Res 58 (2003) 390-398
24. Tateishi-Yuyama E., Matsubara H., Murohara T., et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 360 (2002) 427-435
25. Del Papa N., Quirici N., Soligo D., et al. Bone marrow endothelial progenitors are defective in systemic sclerosis. Arthritis Rheum 54 (2006) 2605-2615
26. Tepper O.M., Galiano R.D., Capla J.M., et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106 (2002) 2781-2786
27. Ito H., Rovira II, Bloom M.L., et al. Endothelial progenitor cells as putative targets for angiostatin. Cancer Res 59 (1999) 5875-5877
28. Yoder M.C., Mead L.E., Prater D., et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 109 (2007) 1801-1809
29. Okamoto M., Okano A., Akamatsu S., et al. Rituximab is effective for steroid-refractory sclerodermatous chronic graft-versus-host disease. Leukemia 20 (2006) 172-173
30. Couriel D.R., Hosing C., Saliba R., et al. Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD. Blood 107 (2006) 3074-3080